Agilent Technologies stock hits 52-week high at 153.85 USD

Published 25/11/2025, 15:38
Agilent Technologies stock hits 52-week high at 153.85 USD

Agilent Technologies stock has reached a new 52-week high, hitting a price of 153.85 USD. This milestone reflects a positive trend for the company, which has experienced a 1-year price return of 15.14%. The stock has shown remarkable momentum with a substantial 42.11% gain over the past six months, according to InvestingPro data. The stock’s performance over the past year highlights the company’s resilience and growth in the market, as it continues to build on its strengths in the analytical and diagnostic sectors. With a market capitalization of $42.72 billion and a P/E ratio of 35.62, Agilent appears somewhat overvalued compared to its InvestingPro Fair Value estimate. Investors are closely watching Agilent Technologies as it navigates the evolving landscape, with this recent high serving as a potential indicator of continued success. InvestingPro identifies several additional strengths for Agilent, including its good financial health score and consistent dividend growth of 8.05% over the last year.

In other recent news, Agilent Technologies reported a strong fourth-quarter performance, exceeding earnings expectations with an earnings per share (EPS) of $1.59, slightly above the forecast of $1.58. The company’s revenue reached $1.86 billion, surpassing predictions by $30 million. Agilent also achieved a 7% organic growth, outperforming the 5% consensus estimate. Leerink Partners responded by raising Agilent’s stock price target to $165, maintaining an Outperform rating. Meanwhile, BofA Securities kept a Neutral rating but increased its price target to $165, acknowledging the company’s strong results. Evercore ISI also raised its price target to $155 from $140, citing Agilent’s robust performance in liquid chromatography and liquid chromatography-mass spectrometry. All three of Agilent’s segments exceeded expectations, with notable growth in the Life Sciences and Diagnostics Group, Agilent CrossLab Group, and Applied Markets Group. These developments reflect Agilent’s strong market position and operational performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.